Deerfield's Biopharma Portfolio

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.

ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.

Lomond Therapeutics creates pharmacological platforms that target escape mutations.

Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3K malignancies.

Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.

Aurion Biotechnologies is a clinical-stage biotech company.

Blade Therapeutics is a discovery stage drug development company.

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.